Statistics for TSNP: A two-stage nonparametric phase I/II clinical trial design for immunotherapy
Total visits
| views | |
|---|---|
| TSNP: A two-stage nonparametric phase I/II clinical trial design for immunotherapy | 130 |
Total visits per month
| views | |
|---|---|
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
| July 2025 | 0 |
File Visits
| views | |
|---|---|
| Han2021TSNP-AAM.pdf | 139 |
| java.util.UUID:5ef044cd-ab91-485d-ac63-480b77634af6 | 34 |
| java.util.UUID:134f45ba-0e43-41d6-933f-db1d3e2912df | 25 |
| java.util.UUID:622b7864-090d-49e7-9c84-c0e5d45dbd43 | 12 |
| nihms-1828502.pdf | 7 |
| java.util.UUID:3d3457ef-7310-4c88-a636-512d7eaa25cf | 6 |
Top country views
| views | |
|---|---|
| United States | 89 |
| United Kingdom | 4 |
| Canada | 3 |
| Japan | 2 |
| South Korea | 2 |
| Slovenia | 2 |
| China | 1 |
| Israel | 1 |
| Malaysia | 1 |
| Russia | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 37 |
| White Plains | 11 |
| Washington | 6 |
| Houston | 5 |
| Ann Arbor | 4 |
| Fairfield | 4 |
| Warrington | 4 |
| Chicago | 3 |
| Collegeville | 3 |
| Concord | 3 |
| Indianapolis | 3 |
| Jacksonville | 3 |
| Burnaby | 2 |
| Cambridge | 2 |
| Ljubljana | 2 |
| Beijing | 1 |
| Columbus | 1 |
| Franklin | 1 |
| Haifa | 1 |
| Omsk | 1 |
| Ottawa | 1 |
| Seoul | 1 |
| Seremban | 1 |